G3QRQ8 (G3QRQ8_GORGO) Gorilla gorilla gorilla (Western lowland gorilla)
Histone deacetylase 2 UniProtKBInterProSTRINGInteractive Modelling
488 aa; Sequence (Fasta) ;
4 identical sequences: Homo sapiens: Q92769; Pan troglodytes: K7B9A4, A0A803KJY1; Piliocolobus tephrosceles: A0A8C9HY57
It is possible new templates exist for this target since these models were created.
Available Structures
40 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Cryo-EM structure of the human SIN3B histone deacetylase core complex with SAHA at 2.8 Angstrom |
Heteromer O75182; Q92769; Q96QT6; | 100 | 1×SHH; 3×ZN; 2×CA; | |||
| Cryo-EM structure of the human SIN3B histone deacetylase complex at 3.7 Angstrom |
Heteromer O75182; Q92769; Q96QT6; Q9UBU8; | 100 | 5×ZN; 2×CA; | |||
| Cryo-EM structure of the human SIN3B full-length complex at 3.4 Angstrom resolution |
Heteromer O75182; Q92769; Q96QT6; Q9UBU8; | 100 | 5×ZN; 2×CA; | |||
| Cryo-EM structure of the human SIN3B histone deacetylase core complex at 2.8 Angstrom |
Heteromer O75182; Q92769; Q96QT6; | 100 | 3×ZN; 2×CA; 1×ACT; | |||
| The structure of HDAC2-CoREST in complex with KBTBD4R313PRR mutant |
Heteromer Q92769; Q9NVX7; Q9UKL0; | 100 | 1×IHP; | |||
| Histone deacetylases complex with peptide macrocycles | monomer | 100 | 1×ZN; 2×NA; 1×NHE; 3×PG4; 1×PGE; 1×PEG; | |||
| Histone deacetylases complex with peptide macrocycles | monomer | 100 | 1×ZN; 2×NA; 2×NHE; 2×PG4; 1×PGE; | |||
| Histone deacetylases complex with peptide macrocycles | monomer | 100 | 1×ZN; 2×NA; 1×NHE; 2×PGE; 1×PG4; | |||
| Histone deacetylases complex with peptide macrocycles | monomer | 100 | 1×ZN; 2×NA; 1×NHE; 1×PGE; 2×PG4; | |||
| Histone deacetylases complex with peptide macrocycles | monomer | 100 | 1×ZN; 2×NA; 2×PGE; | |||
| Structure of HDAC2 complexed with an inhibitory ligand | monomer | 100 | 1×ZN; 1×CA; 1×NA; 1×PGE; 6×EDO; 1×KJ6; 1×2OP; | |||
| Ligand binding to HDAC2 | monomer | 100 | 1×ZN; 1×CA; 1×NA; 2×PEG; 1×PGE; 1×KJF; | |||
| HDAC2 WITH LIGAND BRD7232 | monomer | 100 | 1×ZN; 2×CA; 1×6EZ; 2×PEG; 1×PG4; 1×PG5; 2×PGE; | |||
| Inhibitor binding to HDAC2 | monomer | 100 | 1×ZN; 1×CA; 1×NA; 1×PEG; 1×KRU; | |||
| HDAC2 complexed with an inhibitory ligand | monomer | 100 | 1×ZN; 1×CA; 1×NA; 3×PEG; 1×EDO; 1×SHH; 1×KK0; | |||
| HDAC2 in complex with inhibitory ligand | monomer | 100 | 1×ZN; 1×CA; 1×NA; 4×EDO; 1×KJN; | |||
| Crystal structure of human HDAC2 in complex with (R)-6-[3,4-Dioxo-2-(4-trifluoromethoxy-phenylamino… | monomer | 100 | 1×ZN; 1×CA; 1×NA; 1×EL8; | |||
| Structure of Human HDAC2 in complex with a 2-substituted benzamide inhibitor (compound 20) | monomer | 100 | 1×ZN; 2×CA; 4×SO4; 3×PEG; 1×WBA; | |||
| Structure of Human HDAC2 in complex with an ethyl ketone inhibitor containing a spiro-bicyclic group | monomer | 100 | 1×ZN; 4×SO4; 2×CA; 3×PEG; 1×TV7; | |||
| STRUCTURE OF HUMAN HDAC2 IN COMPLEX WITH KETONE INHIBITOR (COMPOUND E) | monomer | 100 | 1×ZN; 4×SO4; 2×CA; 3×PEG; 1×V1P; | |||
| Structure of HDAC2 in complex with an inhibitor (compound 9) | monomer | 100 | 1×ZN; 4×SO4; 2×CA; 3×PEG; 1×V1P; | |||
| Structure of HDAC2 in complex with a macrocyclic inhibitor (compound 25) | monomer | 100 | 1×ZN; 4×SO4; 2×CA; 3×PEG; 1×ZL4; | |||
| STRUCTURE OF HUMAN HDAC2 IN COMPLEX WITH AN ARYL KETONE INHIBITOR | monomer | 100 | 1×ZN; 2×CA; 4×SO4; 3×PEG; 1×V1D; | |||
| Structure of Human HDAC2 in complex with inhibitor 4-(acetylamino)-N-[2-amino-5-(thiophen-2-yl)phen… | monomer | 100 | 1×ZN; 1×CA; 1×NA; 3×PG4; 1×20Y; | |||
| STRUCTURE OF HUMAN HDAC2 IN COMPLEX WITH AN ETHYL KETONE INHIBITOR CONTAINING A SPIRO-BICYCLIC GROU… | monomer | 100 | 1×ZN; 4×SO4; 2×CA; 3×PEG; 1×VJV; | |||
| HDAC2 WITH LIGAND BRD4884 | monomer | 100 | 1×ZN; 2×CA; 1×IWX; 1×PG5; 2×PGE; | |||
| Structure of HDAC2 in complex with an inhibitor (compound 14) | monomer | 100 | 1×ZN; 4×SO4; 2×CA; 3×PEG; 1×ZLS; | |||
| STRUCTURE OF HUMAN HDAC2 IN COMPLEX WITH KETONE INHIBITOR (COMPOUND O) | monomer | 100 | 1×ZN; 4×SO4; 2×CA; 3×PEG; 1×V1S; | |||
| Structure of HDAC2 in complex with a macrocyclic inhibitor (compound 4) | monomer | 100 | 1×ZN; 5×SO4; 2×CA; 3×PEG; 1×ZLV; | |||
| Structure of HDAC2 in complex with an inhibitor (compound 19) | monomer | 100 | 1×ZN; 4×SO4; 2×CA; 3×PEG; 1×ZLM; | |||
| Structure of Human HDAC2 in complex with SAHA (vorinostat) | monomer | 100 | 1×ZN; 1×CA; 1×NA; 3×PG4; 1×SHH; | |||
| HDAC2 in complex with an inhibitor | monomer | 100 | 1×ZN; 1×CA; 1×NA; 1×KIZ; | |||
| Structure of Human HDAC2 in complex with a 2-substituted benzamide inhibitor (compound 16) | monomer | 100 | 1×ZN; 2×CA; 3×PEG; 1×WB4; | |||
| Structure of Human HDAC2 in complex with an ethyl ketone inhibitor | monomer | 100 | 1×TV1; 1×ZN; 2×CA; 3×PEG; | |||
| STRUCTURE OF HUMAN HDAC2 IN COMPLEX WITH AN INHIBITOR LACKING A ZINC BINDING GROUP (COMPOUND 19) | monomer | 100 | 1×ZN; 4×SO4; 2×CA; 1×ACT; 3×PEG; 1×YEV; | |||
| STRUCTURE OF HUMAN HDAC2 IN COMPLEX WITH AN INHIBITOR THAT LACKS A ZINC BINDING GROUP (COMPOUND 12) | monomer | 100 | 1×ZN; 2×CA; 1×ACT; 3×PEG; 1×YEM; | |||
| Ligand binding to HDAC2 | monomer | 100 | 3×PEG; 1×PG4; 1×EDO; 1×ZN; 1×CA; 1×NA; 1×KKW; 1×KZF; | |||
| STRUCTURE OF HUMAN HDAC2 IN COMPLEX WITH APICIDIN | monomer | 100 | 1×ZN; 2×CA; 3×PEG; 1×YED; | |||
| Inhibitory Ligand binding to HDAC2 | monomer | 100 | 5×EDO; 1×PG4; 3×PEG; 1×ZN; 1×CA; 1×NA; 1×KKI; 1×NHE; | |||
| Crystal Structure of Human HDAC2 complexed with an N-(2-aminophenyl)benzamide | monomer | 100 | 1×ZN; 1×CA; 1×NA; 1×LLX; 1×NHE; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7zzw.2.A | monomer | 0.89 | 1×ZN; 1×CA; 1×KKW; | 100.00 | ||